A detailed history of Mather Group, Llc. transactions in Natera, Inc. stock. As of the latest transaction made, Mather Group, Llc. holds 6 shares of NTRA stock, worth $876. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6
Previous 50 88.0%
Holding current value
$876
Previous $5,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$97.75 - $129.67 $4,301 - $5,705
-44 Reduced 88.0%
6 $0
Q2 2024

Jul 08, 2024

SELL
$85.28 - $112.6 $16,203 - $21,394
-190 Reduced 79.17%
50 $5,000
Q1 2024

Apr 08, 2024

BUY
$59.21 - $92.9 $14,210 - $22,296
240 New
240 $21,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $14.2B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Mather Group, Llc. Portfolio

Follow Mather Group, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mather Group, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Mather Group, Llc. with notifications on news.